Items received in response to the request for public comment published in the Federal Register on November 4, 2011.
NTP invites interested parties to submit written comments or supplementary information on the nominations in the table below. NTP welcomes toxicology study information from completed, ongoing, or anticipated studies, as well as information on current U.S. production levels, use or consumption patterns, human exposure, environmental occurrence, or public health concerns for any of the nominated substances. NTP is interested in identifying appropriate animal and non-animal experimental models for mechanistic-based research, including genetically modified rodents and high-throughput in vitro test methods, and as such, solicits comments regarding the use of specific in vivo and in vitro experimental approaches to address questions relevant to the nominated substances and issues under consideration. Comments should be submitted by December 1, 2011; however, NTP welcomes comments or additional information on these study nominations at any time.
NTP will not respond to submitted comments; however, all information received will be become part of the official record that NTP considers in its ongoing review of these nominations. Persons submitting comments should include their name, affiliation, mailing address, phone, fax, email address, and sponsoring organization (if any) with the submission. Written submissions will be made available on the NTP website here as they are received.
Correspondence should be addressed to:
Dr. Scott A. Masten
Director, Office of Nomination and Selection
Division of the National Toxicology Program
National Institute of Environmental Health Sciences
|Octrizole and related phenolic benzotriazoles|